+919405117673
Giotrif 20mg / 30mg / 40mg Tablets – Afatinib Targeted Cancer Therapy | Trusted Exporter from India
Buy Giotrif Tablets Online – Global Export by Cordium Pharmaceuticals Pvt. Ltd.

Looking for a reliable supplier of Giotrif (Afatinib) 20mg, 30mg, and 40mg tablets?
Cordium Pharmaceuticals Pvt. Ltd. is a trusted pharmaceutical exporter from India, supplying high-quality oncology medicines with fast, secure, and compliant international delivery.

We export to:

United States
Germany
United Kingdom
South Africa
United Arab Emirates
Brazil
Singapore
Australia
Canada
What is Giotrif (Afatinib)? – Complete Product Overview

Giotrif contains the active pharmaceutical ingredient Afatinib Dimaleate, a targeted cancer therapy drug classified as a tyrosine kinase inhibitor (TKI).

It is primarily used in the treatment of:

Non-Small Cell Lung Cancer (NSCLC)
EGFR mutation-positive advanced or metastatic lung cancer
Patients who require targeted oral anticancer therapy

Giotrif works by blocking EGFR, HER2, and related receptors, which helps stop the growth and spread of cancer cells.

Available Strengths

We supply globally in all major strengths:

Giotrif 20 mg Tablets
Giotrif 30 mg Tablets
Giotrif 40 mg Tablets (most commonly prescribed dose)

All tablets are film-coated, prescription-only oncology medicines manufactured under strict pharmaceutical standards.

Key Benefits of Giotrif Tablets

✔ Targeted therapy for EGFR-positive lung cancer
✔ Oral administration (convenient dosing)
✔ Proven clinical efficacy in advanced NSCLC
✔ Slows tumor progression and cell growth
✔ Widely accepted in international oncology protocols

Product Description

Giotrif (Afatinib) is a second-generation irreversible EGFR inhibitor designed for precision oncology treatment. It binds permanently to cancer cell receptors, helping reduce tumor signaling pathways responsible for cancer growth.

It is widely used in first-line and second-line lung cancer treatment protocols across major global healthcare systems.

Medical Indications

Giotrif is indicated for:

EGFR mutation-positive locally advanced or metastatic NSCLC
Patients who have not previously received EGFR-TKI therapy
Squamous cell NSCLC after chemotherapy progression (in specific cases)
Dosage Information (General Medical Reference)
Standard dose: 40 mg once daily
Dose adjustments: 30 mg or 20 mg based on tolerance
Must be taken on an empty stomach
Administer under oncologist supervision only
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
✔ Trusted Indian Pharmaceutical Exporter

We are a licensed and reliable exporter of oncology medicines, ensuring global compliance and safe distribution.

✔ Fast & Reliable International Delivery

We supply to USA, Europe, Middle East, Africa, South America, and Asia-Pacific with efficient logistics support.

✔ Quality Assurance & Compliance

All medicines are sourced from approved manufacturing facilities with strict quality control standards.

✔ Global Supply Chain Expertise

We handle custom clearance, documentation, and pharma export compliance for smooth international shipping.

✔ Bulk & Hospital Supply Capability

We support:

Hospitals
Distributors
Oncology clinics
Government tenders
Wholesale buyers
Export Strengths & Packaging
Secure pharmaceutical-grade packaging
Temperature-safe logistics support
Export documentation assistance
Batch traceability maintained
WHO-GMP certified sourcing support
Global Buyer Intent Keywords (SEO Optimized)


Important Medical Disclaimer

Giotrif (Afatinib) is a prescription-only anticancer medication.
It should only be used under the supervision of a qualified oncologist or healthcare professional.

Contact for Global Supply

Cordium Pharmaceuticals Pvt. Ltd.
Trusted Exporter of Oncology & Specialty Medicines from India

📦 Global Shipping Available
🌍 USA | Europe | Middle East | Africa | Asia-Pacific
Jun 12th, 2026 11:24 AM

Keywords